Loading stock data…
AVXL
$3.42+0.10 (+2.86%)
Market OpenUpdated 2:22 PM EDT
Anavex Life Sciences Corp.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Anavex Life Sciences Corp. in the Healthcare sector is trading at $3.42. The stock is currently near its 52-week low of $2.61, remaining 45.3% below its 200-day moving average. Technical signals show neutral RSI of 60 and bullish MACD crossover, explaining why AVXL maintains its current current market pressure. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 60) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$3.42
Potential Upside
5%
Whystock Fair Value$3.59
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus2 analysts
Mean target$22.00+544.2%
Range$20.00 – $24.00
Fundamentals
Anavex Life Sciences Corp. operates as a biopharmaceutical company. It engages in developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett s...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$334.55M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.18
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-31.55%
Volume
Today's trading volume
467,278
Recent News
AMD downgraded, Airbnb upgraded: Wall Street's top analyst calls
AMD downgraded, Airbnb upgraded: Wall Street's top analyst calls
Exploring Three High Growth Tech Stocks In The US Market
In the last week, the United States market has stayed flat, but over the past 12 months, it has risen by 29%, with earnings expected to grow by 16% per annum in the coming years. In this context of robust growth expectations, identifying high growth tech stocks that align with these trends can be crucial for investors seeking opportunities in a dynamic sector.
What Makes Anavex Life Sciences (AVXL) One of the Best Shorted Penny Stocks
Anavex Life Sciences Corp. (NASDAQ:AVXL) is one of the 10 most shorted penny stocks to buy. More than 500% upside potential as of the April 23 close supports a highly bullish stance on the stock. Recent developments on the ongoing clinical trials also back the argument. On March 23, Anavex Life Sciences Corp. (NASDAQ:AVXL) released […]
Anavex Life Sciences Teases New Pivotal Blarcamesine Trials, Maps Regulatory Path at Needham Conference
Anavex Life Sciences (NASDAQ:AVXL) is prioritizing upcoming pivotal studies and continued regulatory engagement as it seeks potential pathways to market authorization for its oral central nervous system (CNS) drug candidate blarcamesine, company executives said during a Needham conference session ho
3 Promising Penny Stocks With At Least $200M Market Cap
Over the last 7 days, the market has remained flat, but it is up 16% over the past year with earnings forecast to grow by 15% annually. In light of these conditions, identifying stocks with strong financials and a clear growth trajectory can be beneficial. While "penny stocks" might seem like an outdated term, they still represent smaller or less-established companies that could offer significant value.